FI72967B - Foerfarande foer framtaellning av farmaceutiskt aktiva 2-amino-3-bensoylfenylacetamidderivat. - Google Patents

Foerfarande foer framtaellning av farmaceutiskt aktiva 2-amino-3-bensoylfenylacetamidderivat. Download PDF

Info

Publication number
FI72967B
FI72967B FI803002A FI803002A FI72967B FI 72967 B FI72967 B FI 72967B FI 803002 A FI803002 A FI 803002A FI 803002 A FI803002 A FI 803002A FI 72967 B FI72967 B FI 72967B
Authority
FI
Finland
Prior art keywords
amino
mol
solution
added
menetelmä
Prior art date
Application number
FI803002A
Other languages
English (en)
Finnish (fi)
Other versions
FI803002A (fi
FI72967C (sv
Inventor
Jr James Robert Shanklin
David Allan Walsh
Dwight Allen Shamblee
Original Assignee
Robins Co Inc A H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Robins Co Inc A H filed Critical Robins Co Inc A H
Publication of FI803002A publication Critical patent/FI803002A/fi
Publication of FI72967B publication Critical patent/FI72967B/fi
Application granted granted Critical
Publication of FI72967C publication Critical patent/FI72967C/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182Radicals derived from carboxylic acids
    • C07D295/185Radicals derived from carboxylic acids from aliphatic carboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Claims (4)

1. Förfarande för framställning av farmaceutiskt aktiva 2-amino-3-bensoyl-fenylacetamidderivat med formeln
0. R1 n / ch2-c-N ^ r2 χ_γΎ VV c=o Λ
1. Menetelmä farmaseuttisesti aktiivisten 2-amino-3- bentsoyylifenyyliasetamidijohdannaisten valmistamiseksi, joilla on kaava 1 O . R ·· / ch~-c-n x L 1 S^NH2 I c=o jossa 1 2 R ja R ovat toisistaan riippumatta vety tai alempi al-kyyli, tai R ja R muodostavat yhdessä viereisen typpi-atomin kanssa morfolinoryhmän, X on vety tai halogeeni, ja Y on vety tai halogeeni, tunnettu siitä, ette pelkistetään yhdiste, jolla on kaava SR30 r1 2 3 I I» CH-C-NC^^ 2 x~r T γ^Η2 c=o Λ O 2 2 jossa R , R , X ja Y tarkoittavat samaa kuin edellä ja 3 R on fenyyli tai alempi alkyyli. 19 72967
2. Patenttivaatimuksen 1 mukainen menetelmä, tunnettu siitä, että valmistetaan 2-amino-3-bentsoyyli-5-kloorifenyyliasetamidia.
3. Patenttivaatimuksen 1 mukainen menetelmä, tunnettu siitä, että valmistetaan 2-amino-3-bentsoyyli-fenyyliasetamidia.
4. Patenttivaatimuksen 1 mukainen menetelmä, tunnettu siitä, että valmistetaan 2-amino-3-(4-klooribent-soyyli)fenyyliasetamidia.
5. Patenttivaatimuksen 1 mukainen menetelmä, tunnettu siitä, että valmistetaan 2-amino-3-(4-fluoribent-soyyli)fenyyliasetamidia.
4- Y vV väri 1 2 R och R betecknar oberoende av varandra väte eller läg- 1 2 re alkyl, eller R och R bildar tillsammans med den när-belägna kväveatomen en morfolinogrupp,
FI803002A 1979-09-26 1980-09-24 Förfarande för framtällning av farmaceutiskt aktiva 2-amino-3-bensoyl fenylacetamidderivat. FI72967C (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7886079A 1979-09-26 1979-09-26
US7886079 1979-09-26

Publications (3)

Publication Number Publication Date
FI803002A FI803002A (fi) 1981-03-27
FI72967B true FI72967B (fi) 1987-04-30
FI72967C FI72967C (sv) 1987-08-10

Family

ID=22146633

Family Applications (1)

Application Number Title Priority Date Filing Date
FI803002A FI72967C (sv) 1979-09-26 1980-09-24 Förfarande för framtällning av farmaceutiskt aktiva 2-amino-3-bensoyl fenylacetamidderivat.

Country Status (36)

Country Link
JP (1) JPS5657751A (sv)
KR (1) KR840000763B1 (sv)
AT (1) AT374170B (sv)
AU (1) AU532359B2 (sv)
BE (1) BE885393A (sv)
BR (1) BR8006042A (sv)
CA (1) CA1128512A (sv)
CH (1) CH646138A5 (sv)
CS (1) CS227012B2 (sv)
DE (1) DE3035688A1 (sv)
DK (1) DK154136C (sv)
EG (1) EG15020A (sv)
ES (2) ES495329A0 (sv)
FI (1) FI72967C (sv)
FR (1) FR2465710A1 (sv)
GB (1) GB2059963B (sv)
GR (1) GR70049B (sv)
HK (1) HK59383A (sv)
HU (1) HU183215B (sv)
IE (1) IE50268B1 (sv)
IL (1) IL60999A (sv)
IN (3) IN151313B (sv)
IT (1) IT1133823B (sv)
KE (1) KE3307A (sv)
LU (1) LU82797A1 (sv)
MX (1) MX7159E (sv)
NL (1) NL8005346A (sv)
NO (1) NO152128C (sv)
NZ (1) NZ195061A (sv)
PH (1) PH22628A (sv)
PL (1) PL128998B1 (sv)
PT (1) PT71839B (sv)
SE (1) SE448626B (sv)
SG (1) SG42983G (sv)
YU (3) YU41734B (sv)
ZA (1) ZA805476B (sv)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL61945A (en) * 1980-02-19 1984-09-30 Robins Co Inc A H 2-amino-3-(hydroxy(phenyl)methyl)phenylacetic acids,esters and amides and pharmaceutical compositions containing them
US6066671A (en) * 1997-12-19 2000-05-23 Alcon Laboratories, Inc. Treatment of GLC1A glaucoma with 3-benzoyl-phenylacetic acids, esters, or amides
US6646001B2 (en) 1997-12-19 2003-11-11 Alcon Manufacturing, Ltd. Use of non-steroidal anti-inflammatory agents in combination with prostaglandin FP receptor agonists to treat glaucoma and ocular hypertension
GB9727523D0 (en) 1997-12-31 1998-02-25 Pharmacia & Upjohn Spa Alpha-aminoamide derivatives useful as analgesic agents
AR030345A1 (es) * 2000-08-14 2003-08-20 Alcon Inc Metodo de tratamiento de desordenes relacionados con angiogenesis
US8084447B2 (en) 2001-09-03 2011-12-27 Newron Pharmaceuticals S.P.A. Pharmaceutical composition comprising gabapentin or an analogue thereof and an α-aminoamide and its analgesic use
EP1438956A1 (en) 2003-01-16 2004-07-21 Newron Pharmaceuticals S.p.A. Alpha-aminoamide derivatives useful as antimigraine agents
CZ2009367A3 (cs) * 2009-06-08 2010-06-16 Farmak, A.S. Postup prípravy 2-amino-3-benzoylfenylacetamidu (nepafenacu) s minimem vedlejších produktu
CN112794809B (zh) * 2019-11-14 2023-12-29 南京济群医药科技股份有限公司 一种高纯度奈帕芬胺中间体的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1226344A (sv) * 1967-07-31 1971-03-24
SE400966B (sv) * 1975-08-13 1978-04-17 Robins Co Inc A H Forfarande for framstellning av 2-amino-3-(eller 5-)bensoyl-fenylettiksyror
IL61945A (en) * 1980-02-19 1984-09-30 Robins Co Inc A H 2-amino-3-(hydroxy(phenyl)methyl)phenylacetic acids,esters and amides and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
DK405780A (da) 1981-03-27
ES503019A0 (es) 1982-05-01
JPH0141616B2 (sv) 1989-09-06
JPS5657751A (en) 1981-05-20
GB2059963A (en) 1981-04-29
NO152128C (no) 1985-08-07
IE50268B1 (en) 1986-03-19
YU245080A (en) 1983-09-30
IE801946L (en) 1981-03-26
SE8006668L (sv) 1981-03-27
GR70049B (sv) 1982-07-26
IN156255B (sv) 1985-06-08
MX7159E (es) 1987-12-02
FR2465710B1 (sv) 1984-10-12
SG42983G (en) 1985-01-11
PT71839A (en) 1980-10-01
HU183215B (en) 1984-04-28
NZ195061A (en) 1984-04-27
BE885393A (fr) 1981-01-16
GB2059963B (en) 1983-04-20
NO802834L (no) 1981-03-27
CS227012B2 (en) 1984-04-16
HK59383A (en) 1983-12-02
AU532359B2 (en) 1983-09-29
DE3035688C2 (sv) 1990-05-17
ES8200329A1 (es) 1981-10-16
ATA474580A (de) 1983-08-15
SE448626B (sv) 1987-03-09
IT1133823B (it) 1986-07-24
YU43305B (en) 1989-06-30
FR2465710A1 (fr) 1981-03-27
KR840000763B1 (ko) 1984-06-08
YU73083A (en) 1983-12-31
CA1128512A (en) 1982-07-27
CH646138A5 (fr) 1984-11-15
PH22628A (en) 1988-10-28
NO152128B (no) 1985-04-29
YU41734B (en) 1987-12-31
YU43306B (en) 1989-06-30
BR8006042A (pt) 1981-04-07
AU6211680A (en) 1981-04-02
ES495329A0 (es) 1981-10-16
YU73183A (en) 1983-12-31
DE3035688A1 (de) 1981-04-16
IN156254B (sv) 1985-06-08
PT71839B (en) 1981-06-25
IT8024948A0 (it) 1980-09-26
ZA805476B (en) 1981-11-25
IL60999A (en) 1984-05-31
IL60999A0 (en) 1980-11-30
PL128998B1 (en) 1984-03-31
KR830004210A (ko) 1983-07-06
FI803002A (fi) 1981-03-27
EG15020A (en) 1985-03-31
DK154136B (da) 1988-10-17
FI72967C (sv) 1987-08-10
KE3307A (en) 1983-08-19
ES8204715A1 (es) 1982-05-01
NL8005346A (nl) 1981-03-30
AT374170B (de) 1984-03-26
DK154136C (da) 1989-03-06
LU82797A1 (fr) 1982-05-10
IN151313B (sv) 1983-03-26
PL226919A1 (sv) 1982-02-01

Similar Documents

Publication Publication Date Title
FI62821B (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara hydroxamsyror
CA1273019A (en) Enkephalinase inhibitors
US4313949A (en) Method of producing an inhibitory effect on blood platelet aggregation
US7893279B2 (en) Cyclohexanecarboxylic acid compound
FI72967B (fi) Foerfarande foer framtaellning av farmaceutiskt aktiva 2-amino-3-bensoylfenylacetamidderivat.
JPS63295589A (ja) 生理活性物質k−252の誘導体
US4249021A (en) Indanacetic acid compounds
CA2092414A1 (en) N-(2-alkyl-3-mercaptoglutaryl)-amino-diaza cycloalkanone derivatives and their use as collagenase inhibitors
CA1156655A (en) 2-amino-3-[hydroxy(phenyl)methyl] phenylacetic acids, esters and amides
US2844510A (en) Phosphoric acid derivatives of 1-phenyl-2, 3-dimethyl-4-amino-5-pyrazolone
CH647228A5 (de) Substituierte phenylessigsaeureamidverbindungen und verfahren zu ihrer herstellung.
SU1366058A3 (ru) Способ получения;производных иминотиазолидина или их фармацевтически пригодных солей
EP0475214B1 (en) Caffeic acid derivatives and pharmaceutical compositions containing the same
US4897423A (en) Dinitrobenzenesulfonamides
FI68622C (fi) Foerfarande foer framstaellning av indolaettiksyraderivat
FI74457B (fi) Foerfarande foer framstaellning av 2-amino-3-(alkyltiobenzoyl)-fenylaettiksyror.
CZ20012482A3 (cs) Deriváty ((aminoiminomethyl)amino)alkankarboxamidu a jejich pouľití v terapii
FI85140C (sv) Förfarande för framställning av nya terapeutiskt användbara N-(1H-indo l-4-yl)-bensamidderivat
US3821415A (en) Heterocyclic compounds in pharmaceutical compositions and methods
JPS6134424B2 (sv)
EP0137746A2 (en) Nitrogen substituted angiotensin converting enzyme inhibitors
PT85820B (en) Process for the preparation of n-(omega-cyanoalkyl) aminophenols
JPS6310785A (ja) 新規1,2−ジチオ−ル−3−チオン誘導体、その製造方法およびそれを有効成分とする免疫調節剤
KR820001277B1 (ko) 5-치환 피코린산 유도체의 제조법
JPH04312576A (ja) ビピリジル

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: A.H. ROBINS CO INCORPORATED